Skip to main content
logo
Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
10.94
0.00 (0.00%)
Oct 19, 2026, 11:10 AM EDT - Market open

Sutro Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
18199152261464689
Market Cap Growth
174.43%-35.03%-41.98%-43.69%-32.55%-30.31%
Enterprise Value
28-51-212-55193453
Last Close Price
10.9411.5718.4042.9080.80148.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
3.970.962.441.706.8511.13
PB Ratio
--0.743.401.752.142.73
P/TBV Ratio
--3.401.752.142.73
P/OCF Ratio
----130.85-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.61---2.857.32

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.10-0.120.520.230.230.23
Net Debt / Equity Ratio
1.490.95-6.59-2.28-1.31-0.83
Net Debt / EBITDA Ratio
1.221.291.274.152.302.24
Net Debt / FCF Ratio
1.060.701.512.9565.892.16
Asset Turnover
0.200.370.140.350.180.17
Quick Ratio
3.221.942.474.395.135.04
Current Ratio
3.322.012.604.505.315.24
Return on Equity (ROE)
---234.19%-58.25%-50.77%-36.10%
Return on Assets (ROA)
-36.08%-23.38%-34.74%-12.72%-21.54%-16.74%
Return on Capital Employed (ROCE)
-93.10%-106.30%-93.40%-23.70%-37.90%-32.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-99.58%-193.86%-149.92%-40.84%-25.67%-15.33%
FCF Yield
-80.28%-181.52%-128.28%-44.34%-0.93%-14.09%
Buyback Yield / Dilution
-38.81%-9.84%-28.59%-18.57%-10.02%-41.59%
SEC Filings: 10-K · 10-Q